Novo Holdings A/S’s Bolt Biotherapeutics BOLT Stock Holding History

Novo Holdings A/S’s Portfolio BOLT Stock Details BOLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-185,200	Closed	-$5.48M	–	50
2022 Q3	$5.48M	Sell	185,200 -40,000	-18%	-$1.66M	0.26%	44
2022 Q2	$9.19M	Hold	225,200	–	–	0.45%	39
2022 Q1	$12.3M	Hold	225,200	–	–	0.65%	27
2021 Q4	$22.1M	Hold	225,200	–	–	1.05%	18
2021 Q3	$57M	Hold	225,200	–	–	2.95%	9
2021 Q2	$69.6M	Hold	225,200	–	–	3.09%	9
2021 Q1	$148M	Buy	+225,200	New	+$147M	6.12%	4

Other funds holding BOLT

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return